Oncolytics Biotech Inc. (ONCY)
NASDAQ·Healthcare·Biotechnology
$0.90
-7.09%
Mkt Cap $97.22M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | — | — | — | -$0.06 | -$0.08 | -33.33% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.12 | -$0.10 | +16.67% | — | — |
| Q3 2025 Aug 8, 2025 | — | — | — | -$0.11 | -$0.05 | +54.55% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.09 | -$0.06 | +33.33% | — | — |
| Q1 2025 Mar 7, 2025 | — | — | — | -$0.08 | -$0.07 | +12.50% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$0.08 | -$0.09 | -12.50% | — | — |
| Q3 2024 Aug 1, 2024 | — | — | — | -$0.08 | -$0.07 | +12.50% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.09 | -$0.07 | +22.22% | — | — |
| Q1 2024 Mar 7, 2024 | — | — | — | -$0.11 | -$0.04 | +63.64% | — | — |
| Q4 2023 Nov 3, 2023 | — | — | — | -$0.07 | -$0.10 | -42.86% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.09 | -$0.09 | +0.00% | — | — |
| Q2 2023 May 5, 2023 | — | — | — | -$0.07 | -$0.07 | +0.00% | — | — |
| Q1 2023 Mar 3, 2023 | — | — | — | -$0.05 | -$0.10 | -100.00% | — | — |
| Q4 2022 Nov 7, 2022 | — | — | — | -$0.09 | -$0.06 | +33.33% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$0.09 | -$0.07 | +22.22% | — | — |
| Q2 2022 May 5, 2022 | — | — | — | -$0.13 | -$0.09 | +30.77% | — | — |
| Q1 2022 Mar 3, 2022 | — | — | — | -$0.14 | -$0.11 | +21.43% | — | — |
| Q4 2021 Nov 5, 2021 | — | — | — | -$0.15 | -$0.07 | +53.33% | — | — |
| Q3 2021 Aug 6, 2021 | — | — | — | -$0.10 | -$0.11 | -10.00% | — | — |
| Q2 2021 May 7, 2021 | — | — | — | -$0.17 | -$0.10 | +41.18% | — | — |